DE68924157D1 - Implantierte transdermale arzneimittel-verabreichungsanordnung. - Google Patents

Implantierte transdermale arzneimittel-verabreichungsanordnung.

Info

Publication number
DE68924157D1
DE68924157D1 DE68924157T DE68924157T DE68924157D1 DE 68924157 D1 DE68924157 D1 DE 68924157D1 DE 68924157 T DE68924157 T DE 68924157T DE 68924157 T DE68924157 T DE 68924157T DE 68924157 D1 DE68924157 D1 DE 68924157D1
Authority
DE
Germany
Prior art keywords
transdermal drug
layer
anchor
adhesive
source layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE68924157T
Other languages
English (en)
Other versions
DE68924157T2 (de
Inventor
Jesus Miranda
Gary Cleary
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cygnus Inc
Original Assignee
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26852227&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68924157(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cygnus Therapeutic Systems filed Critical Cygnus Therapeutic Systems
Application granted granted Critical
Publication of DE68924157D1 publication Critical patent/DE68924157D1/de
Publication of DE68924157T2 publication Critical patent/DE68924157T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A61F2013/0296—Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Massaging Devices (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE68924157T 1988-02-12 1989-02-10 Implantierte transdermale arzneimittel-verabreichungsanordnung. Revoked DE68924157T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15532788A 1988-02-12 1988-02-12
US07/215,074 US4915950A (en) 1988-02-12 1988-07-05 Printed transdermal drug delivery device
PCT/US1989/000546 WO1989007429A1 (en) 1988-02-12 1989-02-10 Printed transdermal drug delivery device

Publications (2)

Publication Number Publication Date
DE68924157D1 true DE68924157D1 (de) 1995-10-12
DE68924157T2 DE68924157T2 (de) 1996-02-01

Family

ID=26852227

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68924157T Revoked DE68924157T2 (de) 1988-02-12 1989-02-10 Implantierte transdermale arzneimittel-verabreichungsanordnung.

Country Status (15)

Country Link
US (1) US4915950A (de)
EP (1) EP0400078B1 (de)
JP (2) JP2701951B2 (de)
KR (1) KR950001971B1 (de)
AT (1) ATE127331T1 (de)
AU (1) AU639892B2 (de)
CA (1) CA1336324C (de)
DE (1) DE68924157T2 (de)
DK (1) DK191890D0 (de)
ES (1) ES2011416A6 (de)
FI (1) FI903925A0 (de)
IE (1) IE73228B1 (de)
NZ (1) NZ227967A (de)
PT (1) PT89706B (de)
WO (1) WO1989007429A1 (de)

Families Citing this family (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6126963A (en) 1986-08-28 2000-10-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US5820876A (en) 1986-08-28 1998-10-13 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system
US6139868A (en) * 1986-08-28 2000-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
USRE37934E1 (en) 1986-08-28 2002-12-10 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system
US6110488A (en) * 1986-08-28 2000-08-29 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US6117448A (en) * 1986-08-28 2000-09-12 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5124158A (en) * 1988-06-30 1992-06-23 The Upjohn Company Transdermal antisecretory agents for gastrointestinal disease
US5336210A (en) * 1989-02-28 1994-08-09 Teijin Limited Plaster agent
WO1990009784A1 (en) * 1989-02-28 1990-09-07 Teijin Limited Poultice and preparation thereof
US5150722A (en) * 1989-07-12 1992-09-29 International Flavors & Fragrances Inc. Multi-layer scent emitting article and device adapted to employ same
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
US5268179A (en) * 1992-02-14 1993-12-07 Ciba-Geigy Corporation Ultrasonically sealed transdermal drug delivery systems
JP3081858B2 (ja) * 1992-05-12 2000-08-28 日東電工株式会社 貼付剤および貼付製剤
EP0656771A4 (de) * 1992-08-25 1996-07-31 Cygnus Therapeutic Systems Vorrichtung zur transdermalen medikamentenabgabe.
DE4230589C1 (de) * 1992-09-12 1994-02-03 Lohmann Therapie Syst Lts Dosierverfahren für leicht flüchtige oder thermolabile Substanzen in flüssiger Form zur Herstellung von u.a. flächigen Arzneiformen, insbesondere zur Herstellung von transdermalen oder dermalen therapeutischen Systemen
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
CA2160363A1 (en) * 1993-04-13 1994-10-27 Thomas J. Laughlin Foot and shoe deodorizer
AU7568394A (en) * 1993-08-19 1995-03-14 Cygnus Therapeutic Systems Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US6227458B1 (en) 1993-12-03 2001-05-08 Schering-Plough Healthcare Products, Inc. Deodorizer
ATE246909T1 (de) * 1994-03-07 2003-08-15 Theratech Inc Medikament enthaltende, adhesive, zusammenbaubare,transdermale abgabevorrichtung
US5635203A (en) * 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US6861571B1 (en) * 1994-11-28 2005-03-01 The Procter & Gamble Company Article having a lotioned topsheet
US5534263A (en) * 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
US5688523A (en) * 1995-03-31 1997-11-18 Minnesota Mining And Manufacturing Company Method of making a pressure sensitive skin adhesive sheet material
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
EP0764525A3 (de) * 1995-09-19 1997-10-08 Scitex Digital Printing Inc Universelle Vorrichtung des Tintenstrahltyps mit kontinuierlicher Strömung, zum Auftragen einer Oberflächenbeschichtung
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
ES2177962T3 (es) * 1996-03-25 2002-12-16 Lohmann Therapie Syst Lts Sistema de administracion transdermica de reducido espesor de aplicacion y elevada flexibilidad, y proceso de fabricacion del mismo.
SE9601528D0 (sv) 1996-04-23 1996-04-23 Pharmacia Ab Transdermally administered dextromethorphan as antitissue agent
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
US5879701A (en) * 1997-02-28 1999-03-09 Cygnus, Inc. Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
US6096328A (en) * 1997-06-06 2000-08-01 The Procter & Gamble Company Delivery system for an oral care substance using a strip of material having low flexural stiffness
US20020018754A1 (en) * 1999-03-15 2002-02-14 Paul Albert Sagel Shapes for tooth whitening strips
DE19804604A1 (de) * 1998-02-06 1999-08-12 Beiersdorf Ag Vorrichtung zur Freigabe von Stoffen
US5958447A (en) * 1998-03-17 1999-09-28 Plc Holding, L.L.C. Adhesive matrix type transdermal patch and method of manufacturing same
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
US6365183B1 (en) * 1998-05-07 2002-04-02 Alza Corporation Method of fabricating a banded prolonged release active agent dosage form
DE19826592A1 (de) 1998-06-15 1999-12-16 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines aus einzelnen Schichten bestehenden Laminats
USD427370S (en) * 1998-06-15 2000-06-27 Avon Products, Inc. Nose strip
DE19847715A1 (de) * 1998-10-16 2000-04-20 Lohmann Therapie Syst Lts Verfahren zur Behandlung der Schizophrenie sowie Mittel zur Verwendung in diesem Verfahren
US6159497A (en) * 1998-10-30 2000-12-12 Noven Pharmaceuticals, Inc. Patch applicator
EP1140039B1 (de) 1998-12-18 2009-11-04 Alza Corporation Durchsichtige transdermale nicotinabgabevorrichtungen
DE60002471T2 (de) 1999-07-02 2004-02-19 The Procter & Gamble Company, Cincinnati Zusammensetzungen zur freisetzung von mundpflegewirkstoffen enthaltend organosiloxan harze durch verwendung eines wiederablösbaren trägerstreifens
HU225734B1 (en) * 1999-07-28 2007-07-30 Zoltan Dardai Multilayer plaster for introducing peptidaceous pharmacons in living organisms and process for producing thereof
US6974588B1 (en) 1999-12-07 2005-12-13 Elan Pharma International Limited Transdermal patch for delivering volatile liquid drugs
DE10001096A1 (de) * 2000-01-13 2001-07-26 Lohmann Therapie Syst Lts TTS mit Reservoirschicht zur Aufnahme und Abgabe von Duftstoffen
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE10110391A1 (de) * 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
DE10121471A1 (de) * 2001-05-02 2002-11-07 Beiersdorf Ag Oberflächendotierte wirkstoffhaltige Pflaster
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
WO2003024373A1 (en) * 2001-09-14 2003-03-27 3M Innovative Properties Company Non-contact printing method for making a medical pressure sensitive adhesive article
US6723077B2 (en) * 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
US8663687B2 (en) 2001-10-12 2014-03-04 Monosol Rx, Llc Film compositions for delivery of actives
US20070154527A1 (en) * 2001-10-12 2007-07-05 Monosoirx, Llc Topical film compositions for delivery of actives
US7425292B2 (en) * 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US7666337B2 (en) * 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US20060039958A1 (en) * 2003-05-28 2006-02-23 Monosolrx, Llc. Multi-layer films having uniform content
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8765167B2 (en) * 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20070281003A1 (en) * 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US20100021526A1 (en) * 2001-10-12 2010-01-28 Monosol Rx, Llc Ph modulated films for delivery of actives
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US7910641B2 (en) * 2001-10-12 2011-03-22 Monosol Rx, Llc PH modulated films for delivery of actives
US20030111088A1 (en) * 2001-10-29 2003-06-19 Addiction Therapies, Inc. Device and method for treating combination dependencies
US20040137004A1 (en) * 2002-03-19 2004-07-15 Glenn Gregory M Patch for transcutaneous immunization
US20030194420A1 (en) * 2002-04-11 2003-10-16 Richard Holl Process for loading a drug delivery device
US8017150B2 (en) * 2002-04-11 2011-09-13 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
US20060147493A1 (en) * 2002-07-22 2006-07-06 Yang Robert K Packaging and dispensing of rapid dissolve dosage form
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
WO2004020189A1 (en) * 2002-08-30 2004-03-11 Alza Corporation Embossable and writable multilaminate backing construction
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
US8133505B2 (en) * 2002-10-31 2012-03-13 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
IL152574A (en) 2002-10-31 2009-09-22 Transpharma Medical Ltd A system for passing through the skin of dry items or dried medicines
US7662404B2 (en) * 2002-10-31 2010-02-16 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
WO2004041283A1 (en) 2002-10-31 2004-05-21 Recovery Pharmaceuticals, Inc. Device and method for treating combination dependencies
US7383084B2 (en) * 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
ATE295726T1 (de) * 2002-12-02 2005-06-15 Sanol Arznei Schwarz Gmbh Verabreichung von rotigotine zur behandlung der parkinson'schen krankheit durch iontophorese
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
JP3811127B2 (ja) * 2003-01-30 2006-08-16 株式会社東芝 情報記録装置及び情報記録方法
US20070031463A1 (en) * 2003-02-26 2007-02-08 Spiros Fotinos Methods and devices for releasing volatile substances
US8784874B2 (en) * 2003-09-10 2014-07-22 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
CN100457064C (zh) * 2003-10-28 2009-02-04 诺芬药品公司 透皮递药装置
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US9205062B2 (en) * 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
WO2005089728A2 (en) * 2004-03-19 2005-09-29 Pfizer Health Ab Means for transdermal administration of nicotine
WO2005110418A2 (en) 2004-05-07 2005-11-24 Phytotox Limited Transdermal administration of phycotoxins
WO2006041907A2 (en) * 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Transdermal delivery of estradiol
US10130801B1 (en) 2005-02-07 2018-11-20 Ipventure, Inc. Electronic transdermal chemical delivery
US7309809B2 (en) * 2005-02-26 2007-12-18 Xennovate Medical Llc Adhesive attachment and removal device
FR2884143B1 (fr) * 2005-04-08 2007-06-22 Millet Innovation Sa Timbre dermique rechargeable
JP2006320358A (ja) * 2005-05-17 2006-11-30 Nitto Denko Corp 皮膚貼付材用フィルム基材及び皮膚貼付材
WO2006131931A2 (en) * 2005-06-10 2006-12-14 Transpharma Medical, Ltd. Patch for transdermal drug delivery
TWI419717B (zh) * 2005-06-17 2013-12-21 Altea Therapeutics Corp 滲透傳送系統及其使用方法
DE102005033543A1 (de) * 2005-07-14 2007-01-18 Grünenthal GmbH Ein einen Duftstoff aufweisendes transdermales therapeutisches System
CN1778296B (zh) * 2005-07-19 2010-04-14 淮北辉克药业有限公司 他汀类药物的长效制剂
IL177071A0 (en) * 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
ES2499067T3 (es) 2005-10-13 2014-09-26 Nitto Denko Corporation Preparación transdérmica de nicotina y método de producción de la misma
US7888422B2 (en) * 2005-11-09 2011-02-15 Mylan Technologies Inc. Long-wearing removable pressure sensitive adhesive
DE102006026060B4 (de) * 2006-01-12 2013-01-31 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System enthaltend als Wirkstoff Nikotin und Verfahren zur Herstellung solcher Systeme
US20070172515A1 (en) * 2006-01-20 2007-07-26 Monosolrx, Llc Film bandage for mucosal administration of actives
US20070190157A1 (en) * 2006-01-20 2007-08-16 Monosoirx, Llc. Film lined packaging and method of making same
CN101516331A (zh) * 2006-09-20 2009-08-26 莫诺索尔克斯有限公司 含有抗泡沫调味剂的可食用水溶性膜
US20080081071A1 (en) * 2006-09-29 2008-04-03 Pradeep Sanghvi Film Embedded Packaging and Method of Making Same
JP4327841B2 (ja) * 2006-12-20 2009-09-09 日東電工株式会社 経皮吸収製剤の製造装置および製造方法
EP1987815A1 (de) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Im Mund-Nasen-Rachenraum verabreichbare pharmazeutische Zusammensetzungen enthaltend Dopaminagonisten zur Vorbeugung und/oder Behandlung von unruhigen Gliedmassen
US20080292855A1 (en) * 2007-05-21 2008-11-27 Manderfield Cary E Methods of delivering fragrance using ethylene vinyl acetate ribbon
WO2009005814A2 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
US9017301B2 (en) * 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner
JP5508272B2 (ja) * 2007-10-29 2014-05-28 トランスファーマ メディカル リミテッド 垂直的なパッチ乾燥
JP5535497B2 (ja) * 2008-03-06 2014-07-02 リンテック株式会社 経皮吸収貼付剤
JP5460971B2 (ja) * 2008-03-28 2014-04-02 リンテック株式会社 経皮吸収貼付剤
US8231906B2 (en) 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
DE102008059727B4 (de) * 2008-12-01 2012-03-22 Lts Lohmann Therapie-Systeme Ag Duftendes Tattoo-Pflaster. Verfahren zu seiner Herstellung und seine Verwendung
EP2415041B1 (de) 2009-03-31 2018-11-21 Sanofi-Aventis Deutschland GmbH Verfahren zur herstellung eines medikamentenverabreichungseinrichtungskörpers unter verwendung eines klebers und medikamentenverabreichungseinrichtungskörper
JP5583366B2 (ja) * 2009-07-01 2014-09-03 大日本スクリーン製造株式会社 貼付剤の製造方法
US8475832B2 (en) * 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
DK2557924T3 (da) 2010-04-13 2019-09-23 Relmada Therapeutics Inc Dermale farmaceutiske sammensætninger af 1-methyl-2',6'-pipecoloxylidid og fremgangsmåde til deres anvendelse
CN103209681B (zh) 2010-06-10 2017-05-24 Mida科技有限公司 纳米颗粒薄膜递送系统
JP5651076B2 (ja) * 2010-06-29 2015-01-07 花王株式会社 ナノファイバ積層シート
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
DE102011088909A1 (de) * 2011-08-12 2013-02-14 Labtec Gmbh Verfahren zur Herstellung und Kontrolle von oralen Wirkstoff-Filmen
IN2014CN04311A (de) * 2011-12-13 2015-09-04 3M Innovative Properties Co
EP2908798B1 (de) 2012-10-17 2018-08-22 The Procter and Gamble Company Streifen zur verabreichung eines mundpflegewirkstoffes und verfahren zum aufbringen von mundpflegewirkstoffen
DE102014000200A1 (de) * 2014-01-03 2015-07-09 Michael Horstmann Transdermales Therapeutisches System
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
CA3022840A1 (en) 2016-05-05 2017-11-09 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US4460372A (en) * 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
JPS58148815A (ja) * 1982-02-26 1983-09-05 Nitto Electric Ind Co Ltd 複合医薬製剤の製法
US4605548A (en) * 1983-05-31 1986-08-12 Nitto Electric Industrial Co., Ltd. Drug administration material
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4597961A (en) * 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
US4743249A (en) * 1986-02-14 1988-05-10 Ciba-Geigy Corp. Dermal and transdermal patches having a discontinuous pattern adhesive layer
US4784857A (en) * 1986-06-03 1988-11-15 Smith And Nephew Associated Companies Plc Drug delivery device, its preparation and use
DE3629304A1 (de) * 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
FR2604765B1 (fr) * 1986-10-07 1991-03-29 Citroen Messian Durand Engren Reducteur a couple divise
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device

Also Published As

Publication number Publication date
ES2011416A6 (es) 1990-01-01
CA1336324C (en) 1995-07-18
DE68924157T2 (de) 1996-02-01
NZ227967A (en) 1991-11-26
KR900700065A (ko) 1990-08-11
EP0400078B1 (de) 1995-09-06
ATE127331T1 (de) 1995-09-15
US4915950A (en) 1990-04-10
DK191890A (da) 1990-08-13
WO1989007429A1 (en) 1989-08-24
IE890453L (en) 1989-08-12
PT89706A (pt) 1989-10-04
JPH0881364A (ja) 1996-03-26
IE73228B1 (en) 1997-05-21
FI903925A0 (fi) 1990-08-08
EP0400078A4 (en) 1991-04-10
EP0400078A1 (de) 1990-12-05
JP2701951B2 (ja) 1998-01-21
AU639892B2 (en) 1993-08-12
PT89706B (pt) 1994-03-31
KR950001971B1 (ko) 1995-03-08
DK191890D0 (da) 1990-08-13
JPH03505044A (ja) 1991-11-07
AU4031289A (en) 1989-09-06
JP2708391B2 (ja) 1998-02-04

Similar Documents

Publication Publication Date Title
ATE127331T1 (de) Implantierte transdermale arzneimittel- verabreichungsanordnung.
DE69531488D1 (de) Medikament enthaltende, adhesive, zusammenbaubare, transdermale abgabevorrichtung
CA2064687A1 (en) Method and device for administering dexmedetomidine transdermaly
ATE5563T1 (de) Therapeutisches system zum zufuehren von arzneimitteln zur haut.
DE69426988T2 (de) Transdermale abgabe vorrichtung
WO2001026705A3 (en) A dual adhesive transdermal drug delivery system
JPH02264715A (ja) 活性物質の皮膚経由又は粘液経由投薬の為の医療用デバイス
CA2053272A1 (en) Device for administering an active agent to the skin or mucosa
ATE119019T1 (de) Geschichtete zusammensetzung für die transdermale verabreichung von fentanyl.
NO901127L (no) Fremgangsmaate ved fremstilling av et plaster som transdermalt terapeutisk system for avgivelse av virkestoffer paa huden med en trinnvis virkestoffavgivelse samt anvendelse.
MY103355A (en) Active substance-containing plaster of the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin
DK324687A (da) Transdermalt farmeceutisk praeparat
WO1997021430A3 (de) Flächenstabilisierte pharmazeutische zubereitung zur anwendung auf der haut
MY113222A (en) Medicinal patches for percutaneous administration
JP2001026519A (ja) ゲルシート
LV10749A (lv) Transdermala terapeitiska sistema fizostigmina uzliksanai uz adas un tas izgatavosanas panemiens
JPS6038646Y2 (ja) 生理活性物質供給体

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: CYGNUS, INC., DOVER, DEL., US

8331 Complete revocation